[Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations manually curated.
DisGeNET evidence - CURATED